Mirra-Angio

Dosage form Application area Recommendations for use Contraindications Manufacturer
Read on
Certificate number:RU.77.99.88.003.Е.009684.10.15
Date of registration and renewal:20.10.2015
Dosage form: & nbspTablets weighing 0.5 g.
Classification "Composition" & nbsp Other dietary supplements
Classification "Clinical" & nbsp Supplements antioxidants Supplements that support the function of the cardiovascular system
Composition: & nbspIngredients: MCC, ascorbic acid, ginkgo biloba extract, verbena extract, grape seed extract, dihydroquercetin.
Scope: & nbspTo sell to the population through the pharmacy network and specialized stores, the trade network departments as a biologically active food additive supplementary source of vitamin C, a source of dihydroquercetin and proanthocyanidins containing flavonol glycosides.
Suggested Usage: & nbspAdults take 1 tablet 1 time per day with meals. Duration of admission is 25 days.
Contraindications:Individual intolerance of components, pregnancy, breast-feeding.
Special instructions:Before use, it is recommended to consult a doctor.
Shelf life:2 years.
Storage conditions:Store in a dry place, protected from light and out of reach of children, at a temperature not exceeding + 25 ° С.
Research protocols:Expert conclusion of the Federal State Research Institution "NII Nutrition" No. 72 / E-1190 / b-15 of August 20, 2015.
Recipient:Mirra-M, ZAOMirra-M, ZAO Russian Federation
Information update date: & nbsp13.04.16
Instructions
Up